Acute heart failure with preserved ejection fraction: Unique patient characteristics and targets for therapy

Kalkidan Bishu, Margaret May Redfield

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Currently, there are 1.0 million annual hospital discharges for acute heart failure (AHF). The total cost of heart failure (HF) care in the United States is projected to increase to 53 billion in 2030, with the majority of costs (80 %) related to AHF hospitalizations. Approximately 50 % of AHF episodes occur in patients with preserved ejection fraction (HFpEF). There is a dearth of evidence-based guidelines for the management of AHF in HFpEF patients. Here, we briefly review the epidemiology, pathophysiology, and treatment of AHF patients with HFpEF.

Original languageEnglish (US)
Pages (from-to)190-197
Number of pages8
JournalCurrent Heart Failure Reports
Volume10
Issue number3
DOIs
StatePublished - Sep 2013

Fingerprint

Heart Failure
Therapeutics
Costs and Cost Analysis
Epidemiology
Costs
Hospitalization
Guidelines

Keywords

  • Heart failure with preserved ejection fraction

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)
  • Emergency Medicine

Cite this

Acute heart failure with preserved ejection fraction : Unique patient characteristics and targets for therapy. / Bishu, Kalkidan; Redfield, Margaret May.

In: Current Heart Failure Reports, Vol. 10, No. 3, 09.2013, p. 190-197.

Research output: Contribution to journalArticle

@article{95bea83ec5e94ac6a21f0d9a4cd47a18,
title = "Acute heart failure with preserved ejection fraction: Unique patient characteristics and targets for therapy",
abstract = "Currently, there are 1.0 million annual hospital discharges for acute heart failure (AHF). The total cost of heart failure (HF) care in the United States is projected to increase to 53 billion in 2030, with the majority of costs (80 {\%}) related to AHF hospitalizations. Approximately 50 {\%} of AHF episodes occur in patients with preserved ejection fraction (HFpEF). There is a dearth of evidence-based guidelines for the management of AHF in HFpEF patients. Here, we briefly review the epidemiology, pathophysiology, and treatment of AHF patients with HFpEF.",
keywords = "Heart failure with preserved ejection fraction",
author = "Kalkidan Bishu and Redfield, {Margaret May}",
year = "2013",
month = "9",
doi = "10.1007/s11897-013-0149-5",
language = "English (US)",
volume = "10",
pages = "190--197",
journal = "PLoS Medicine",
issn = "1549-1277",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Acute heart failure with preserved ejection fraction

T2 - Unique patient characteristics and targets for therapy

AU - Bishu, Kalkidan

AU - Redfield, Margaret May

PY - 2013/9

Y1 - 2013/9

N2 - Currently, there are 1.0 million annual hospital discharges for acute heart failure (AHF). The total cost of heart failure (HF) care in the United States is projected to increase to 53 billion in 2030, with the majority of costs (80 %) related to AHF hospitalizations. Approximately 50 % of AHF episodes occur in patients with preserved ejection fraction (HFpEF). There is a dearth of evidence-based guidelines for the management of AHF in HFpEF patients. Here, we briefly review the epidemiology, pathophysiology, and treatment of AHF patients with HFpEF.

AB - Currently, there are 1.0 million annual hospital discharges for acute heart failure (AHF). The total cost of heart failure (HF) care in the United States is projected to increase to 53 billion in 2030, with the majority of costs (80 %) related to AHF hospitalizations. Approximately 50 % of AHF episodes occur in patients with preserved ejection fraction (HFpEF). There is a dearth of evidence-based guidelines for the management of AHF in HFpEF patients. Here, we briefly review the epidemiology, pathophysiology, and treatment of AHF patients with HFpEF.

KW - Heart failure with preserved ejection fraction

UR - http://www.scopus.com/inward/record.url?scp=84881479017&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84881479017&partnerID=8YFLogxK

U2 - 10.1007/s11897-013-0149-5

DO - 10.1007/s11897-013-0149-5

M3 - Article

C2 - 23868335

AN - SCOPUS:84881479017

VL - 10

SP - 190

EP - 197

JO - PLoS Medicine

JF - PLoS Medicine

SN - 1549-1277

IS - 3

ER -